foxo4-dri peptide senolytic study Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Buy FOXO4 DRI UK 98% Purity Next Day Dispatch FOXO4 DRI 10mg Senolytic Research Peptide Kalyx Labs FOXO4 DRI Beverly Hills Rejuvenation Center
Pay in 4 interest-free payments of $5.12 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10



